Adial Pharmaceuticals (ADIL) Operating Leases (2022 - 2023)
Adial Pharmaceuticals' Operating Leases history spans 2 years, with the latest figure at $135045.0 for Q1 2023.
- For Q1 2023, Operating Leases fell 30.32% year-over-year to $135045.0; the TTM value through Mar 2023 reached $135045.0, down 30.32%, while the annual FY2022 figure was $150547.0, N/A changed from the prior year.
- Operating Leases for Q1 2023 was $135045.0 at Adial Pharmaceuticals, down from $150547.0 in the prior quarter.
- Across five years, Operating Leases topped out at $193797.0 in Q1 2022 and bottomed at $135045.0 in Q1 2023.